The groundbreaking treatment of the medication represents a exciting breakthrough in the handling of the condition. Different to existing drugs, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – resulting in greater sugar management and potential reduction in weight. Researchers are investigating its future benefits and place in th